scorecardresearch
Add as a preferred source on Google
Wednesday, April 1, 2026
TopicAIDS

Topic: AIDS

China’s method to boost birth rates in country – adding tax to condoms

Under the revised value-added tax law, consumers will pay a 13% levy on items that had been exempted since 1993, when China enforced a strict one-child policy.

Safe access to HIV medication is wrapped in stigma. This non-profit is changing that

Getting quick access to PEP is important because the course must be started within 72 hours of a potential exposure to HIV to be effective. That's the gap the directory aims to fill.

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

Climate crisis could increase HIV infections and AIDS related deaths, UN warns

At the COP29 in Baku, UNAIDS and UNDP presented a report that highlights how climate change could exacerbate existing vulnerabilities to HIV.

More people dying from lack of access to antibiotics. It is leading to rise in drug resistance

By 2050, the total number of deaths associated with drug resistance are expected to reach a staggering 169 million.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

New hope for HIV cure as third patient shows signs of remission after stem cell transplant

Senior physician Björn-Erik Ole Jensen says allogeneic hematopoietic stem cell transplant is a strong answer to curing HIV-1

Manforce AIDS campaign is confused about what to market—awareness or social responsibility

In 2020, Manforce campaign asked Indians to use condoms without thinking about the brand, a clever way to build goodwill. This time it has fallen short.

New drugs mean AIDS is no longer life-limiting. But here’s why elderly will be left out

The threats and implications of HIV infection for older people are as serious as they are for younger age groups.

On Camera

RBI delays stricter trading loan rules as volatility climbs amid Iran conflict

The rules now take effect on 1 July instead of 1 April, the Reserve Bank of India said. New rules may raise cost of raising capital for proprietary trading firms & squeeze profits.

More ‘hits’ than Rheinmetall ever—Ukraine drone manufacturer claps back at CEO’s ‘housewives’ remark

Oleksandr Yakovenko, founder of Ukrainian drone maker TAF Industries, further went on to highlight the growing 'irrelevance' of European defence platforms.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.